EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 86 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $768,000 | +22.1% | 102,103 | +2.3% | 0.00% | – |
| Q2 2022 | $629,000 | -36.5% | 99,794 | -12.9% | 0.00% | – |
| Q1 2022 | $990,000 | +56.9% | 114,561 | -3.8% | 0.00% | – |
| Q4 2021 | $631,000 | -33.7% | 119,087 | -9.7% | 0.00% | – |
| Q3 2021 | $952,000 | -13.8% | 131,945 | +1.7% | 0.00% | – |
| Q2 2021 | $1,105,000 | +11.5% | 129,754 | +15.9% | 0.00% | – |
| Q1 2021 | $991,000 | -30.4% | 111,939 | -3.4% | 0.00% | – |
| Q4 2020 | $1,424,000 | +81.9% | 115,910 | +20.4% | 0.00% | – |
| Q3 2020 | $783,000 | -14.9% | 96,271 | +0.4% | 0.00% | – |
| Q2 2020 | $920,000 | -42.4% | 95,840 | -59.2% | 0.00% | -100.0% |
| Q1 2020 | $1,596,000 | +35.6% | 234,665 | +196.9% | 0.00% | – |
| Q4 2019 | $1,177,000 | +92.6% | 79,027 | +32.4% | 0.00% | – |
| Q3 2019 | $611,000 | -40.6% | 59,680 | -38.5% | 0.00% | – |
| Q2 2019 | $1,029,000 | – | 97,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |